- Home
- KEN vs CLDX Comparison
KEN vs CLDX Comparison
Compare KEN & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KEN | CLDX |
|---|---|---|
| Founded | 2014 | N/A |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.0B |
| IPO Year | 2014 | 1995 |
Fundamental Metrics
Financial Performance| Metric | KEN | CLDX |
|---|---|---|
| Price | $57.29 | $30.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 15 |
| Target Price | N/A | ★ $63.07 |
| AVG Volume (30 Days) | 13.5K | ★ 1.1M |
| Earning Date | 12-02-2026 | 11-05-2026 |
| Dividend Yield | ★ 6.66% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,743,000.00 |
| Revenue This Year | N/A | $19.74 |
| Revenue Next Year | N/A | $373.52 |
| P/E Ratio | $9.21 | ★ N/A |
| Revenue Growth | N/A | ★ 87.78 |
| 52 Week Low | $54.56 | $22.10 |
| 52 Week High | $95.93 | $45.14 |
Technical Indicators
Market Signals| Indicator | KEN | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 37.34 | 47.63 |
| Support Level | N/A | $28.34 |
| Resistance Level | $69.98 | $31.47 |
| Average True Range (ATR) | 1.37 | 1.37 |
| MACD | -0.74 | 0.28 |
| Stochastic Oscillator | 3.90 | 68.39 |
Price Performance
Historical ComparisonAbout KEN Kenon Holdings Ltd.
Kenon Holdings Ltd is a holding company that operates dynamic, growth-oriented businesses. The company's operating segments include: OPC Power Plants, which generates and supplies electricity and energy in Israel; and CPV Group, which generates and supplies electricity and energy in the United States. It generates maximum revenue from the OPC Power Plants segment, which generates and supplies electricity and energy in Israel. CPV Group is a limited partnership owned by OPC, which generates and supplies electricity and energy in the United States. Geographically, the company generates a majority of its revenue from Israel and the rest from the United States.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.